Companies: 10,795·Total market cap: $144.5T
SI-BONE, Inc.

SI-BONE, Inc.

SIBNNASDAQHealthcare● Active
$15.14
+$0.02(+0.13%)
Market Cap$671448145
P/E Ratio
52W High$21.89
52W Low$11.48

SI-BONE, Inc. (SIBN) PE Ratio — Current & Historical Data

Trailing twelve months (TTM) P/E, forward P/E, PEG, and annual PE history — from market prices and filings.

sibn · pe ratio · data through Dec 31, 2025

Core PE Ratio Metrics

Trailing 12 months · TTM

The price-to-earnings (P/E) ratio for SI-BONE, Inc. (SIBN) measures how much investors pay for each dollar of the company's trailing earnings. SIBN's current PE ratio of N/A is calculated by dividing its stock price of $15.14 by its TTM earnings per share of -$0.38.

N/A
P/E Ratio (TTM)N/A — Company is not profitable (TTM)

Source: FMP · /ratios-ttm · /analyst-estimates · 2025-12-31

Forward P/E
N/A
FY2027 est. EPS $-0.36
Based on 6 analysts
EPS (TTM)
-$0.38
TTM · diluted EPS
PEG Ratio
-0.72
Source: FMP · /ratios-ttm · /ratios annual · /analyst-estimates · /stock-peers · SI-BONE, Inc. SEC 10-K & 10-Q filings · US GAAPUpdated: 2026-06-08

PE Ratio History

2012 – 2025 · Annual
PE Ratio (TTM)
EPS (Annual)

▸ FMP /ratios?period=annual&limit=20 · priceToEarningsRatio + netIncomePerShare (Annual)

PE Ratio vs Peers

Medical - Devices · 6 peers · Annual PE
CompanyMarket CapPE (Annual)vs AvgEPS (TTM)
SI-BONE, Inc.
SI-BONE, Inc.You
SIBN
$671MN/A-$0.38
AirSculpt Technologies, Inc.
AirSculpt Technologies, Inc.
AIRS
$375MN/A-$0.19
Aquestive Therapeutics, Inc.
Aquestive Therapeutics, Inc.
AQST
$396MN/A-$0.69
Avanos Medical, Inc.
Avanos Medical, Inc.
AVNS
$1.2BN/A-$1.46
Anavex Life Sciences Corp.
Anavex Life Sciences Corp.
AVXL
$238MN/A-$0.54
Butterfly Network, Inc.
Butterfly Network, Inc.
BFLY
$1.2BN/A-$0.31
ClearPoint Neuro, Inc.
ClearPoint Neuro, Inc.
CLPT
$387MN/A-$0.90

* N/A — Company is not profitable (TTM) · excluded from industry average · ▸ FMP /stock-peers + /ratios?limit=1 · priceToEarningsRatio

Annual PE Ratio History

Showing 10 of 14 years
Fiscal Year EndPE RatioEPS (TTM)YoY ChangePE vs Max
2025-12-31Latest
FY2025
$-0.43
2024-12-31
FY2024
$-0.75
2023-12-31
FY2023
$-1.13
2022-12-31
FY2022
$-1.79
2021-12-31
FY2021
$-1.71
2020-12-31
FY2020
$-1.50
2019-12-31
FY2019
$-1.55
2018-12-31
FY2018
$-1.10
2017-12-31
FY2017
$-1.66
2016-12-31
FY2016
$-1.33

▸ FMP /ratios?period=annual&limit=20 · priceToEarningsRatio + netIncomePerShare · Zero extra API

About PE Ratio & Methodology

The price-to-earnings (P/E) ratio for SI-BONE, Inc. (SIBN) measures how much investors pay for each dollar of the company's trailing earnings. SIBN's current PE ratio of N/A is calculated by dividing its stock price of $15.14 by its TTM earnings per share of -$0.38.

PE Ratio = Stock Price ÷ EPS (TTM)
= $15.14 ÷ -$0.38 = N/A
TTMTrailing Twelve Months — sum of the most recent 4 quarterly EPS figures
Forward PEStock price ÷ analyst consensus EPS estimate for the next fiscal year
PEGPE ÷ earnings growth rate — values below 1.0 suggest growth may justify the premium
Figures tie to SEC 10-K/10-Q and FMP ratio endpoints where noted.

Frequently asked questions

SIBN pe ratio · 6 questions

SIBN's current PE ratio is N/A as of 2026-06-08, based on a stock price of $15.14 and TTM EPS of -$0.38. Data sourced from Financial Modeling Prep via SIBN's SEC 10-K and 10-Q filings.

SIBN PE ratioWhat is SIBN PE ratioCurrent PE ratio of SIBNSIBN PE ratio today

Source: FMP · /ratios-ttm · /ratios annual · /analyst-estimates · /stock-peers · SI-BONE, Inc. SEC 10-K & 10-Q filings · US GAAP · Updated: 2026-06-08